Full Prescribing Information
Patient Prescribing Information
Important Safety Information
HIV Specialist
ASO Finder
Zip Code:
Distance:
HIV Specialist
ASO Finder
Zip Code:
Distance:
Add HIV Specialist
REGISTER FOR UPDATES

Register to receive updates about TRUVADA.

About TRUVADA

TRUVADA is an anti-HIV-1 drug in the nucleoside reverse transcriptase inhibitor (NRTI or "nuke") family. TRUVADA is a combination of 2 NRTIs (2-NRTI). TRUVADA is for use in combination with other HIV-1 medicines to treat HIV-1 infection in adults.

The usual dose of TRUVADA is 1 tablet once a day in combination with other HIV meds. People who have kidney problems may need to take TRUVADA less often. TRUVADA may be taken with or without a meal because food does not affect how TRUVADA works.

The meds in TRUVADA are DHHS-preferred in patients new to HIV therapy and are used once a day in combination.

On December 1, 2009, the U.S. Department of Health and Human Services (DHHS) released an update of the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. For patients who are new to treatment ("treatment naïve"), the newly updated DHHS Guidelines list the meds in TRUVADA as the base for all DHHS-preferred regimens, except for pregnant women, for use in combination HIV therapy for patients new to treatment.

TRUVADA is the #1 prescribed NRTI backbone with Reyataz® (atazanavir sulfate), Prezista® (darunavir), Lexiva® (fosamprenavir calcium), Kaletra® (lopinavir/ritonavir), and Isentress® (raltegravir).*

Important Safety Information

Drug interactions have been observed between tenofovir DF and atazanavir or lopinavir/ritonavir. Atazanavir 300 mg should be boosted with ritonavir 100 mg and taken with food when administered with TRUVADA. Atazanavir without ritonavir should not be coadministered with TRUVADA. Patients on atazanavir or lopinavir/ritonavir plus TRUVADA should be monitored for TRUVADA-associated adverse reactions. TRUVADA should be discontinued in patients who develop TRUVADA-associated adverse reactions.

Watch the Video - How TRUVADA Works

Next: Learn how the meds in TRUVADA work to help fight HIV

Patients should read the Patient Information, including "What is the most important information I should know about TRUVADA?". It is important that you discuss your treatment options and any questions that you may have with your healthcare provider.

Please read the Full Prescribing Information for TRUVADA, EMTRIVA, and VIREAD, including Boxed WARNINGS.

Please read the Full Prescribing Information for TRUVADA, ATRIPLA, EMTRIVA, and VIREAD, including Boxed WARNINGS.

*Synovate Healthcare Data; U.S. HIV Monitor, Q3, 2009.